Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

BACKGROUND: Voriconazole is a first-line agent for the prevention and treatment of a number of invasive fungal diseases. Relatively little is known about the relationship between drug exposure and the prevention of invasive fungal infections. PATIENTS AND METHODS: A pharmacokinetic–pharmacodynamic s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Hope, William W., Walsh, Thomas J., Goodwin, Joanne, Peloquin, Charles A., Howard, Alan, Kurtzberg, Joanne, Mendizabal, Alan, Confer, Dennis L., Bulitta, Jürgen, Baden, Lindsey R., Neely, Michael N., Wingard, John R.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4954923/
https://ncbi.nlm.nih.gov/pubmed/27121401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados